Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma.

Kazuhiro SuzukiShoji NagaoMoyu NaritaHiroshi NakazawaTakashi ShibutaniKasumi YamamotoTomoatsu JimiHiroko YanoMiho KitaiTakaya ShiozakiKazuko MatsuokaSatoshi Yamaguchi

Published in: International journal of clinical oncology (2021)

The addition of concurrent chemoradiotherapy after radical hysterectomy did not significantly improve survival among patients with pelvic node-positive cervical adenocarcinoma. More appropriate treatment strategies are needed to improve the survival outcomes of these patients.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
radiation therapy
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
free survival